Bell Bio

Beijing Bell Bioengineering Joint-stock Co., Ltd. was established in 1995. It is a high-tech enterprise specializing in the research, development, production, and sales of in vitro diagnostic reagents and their supporting instruments. It is a national 'Little Giant' enterprise specializing in refined, distinctive, and innovative technologies, a Beijing municipal 'Little Giant' enterprise in the same category, and a Beijing Enterprise Technology Center. Founded thirty years ago, as one of the early domestic companies engaged in the research, production, and sales of in vitro diagnostic products, the company has always insisted on independent research and development and regards technological innovation as the primary driving force. It has established a comprehensive and strict scientific research, production, and quality system. Currently, it has formed eight major technology platforms, including enzyme-linked immunosorbent assay diagnostic reagents, POCT rapid diagnostic reagents, magnetic microparticle chemiluminescence in vitro diagnostic reagents, molecular PCR reagents, biochemical reagents, mass spectrometry detection reagents, medical instruments, and biological materials. It has established a complete industrial chain covering reagents, instruments, quality control materials, and consumables. Bell Bio has a wide range of products and production lines, with over 420 medical registration certificates. The company conducts in-depth research on pathogens in specific disease categories and has formed more than ten product lines, including respiratory pathogen series, prenatal and postnatal care series, hepatitis virus series, EB virus series, autoimmune antibody series, thyroid function series, sex hormone series, tumor marker series, cardiovascular and hypertension series, making it one of the enterprises with a relatively rich product portfolio in the IVD field. Bell Bio has applied for more than 20 patents and has established a complete independent intellectual property system with strong scientific research strength. It has successively undertaken major scientific research projects such as the National 863 Program, the National Twelfth Five-Year Plan, the National Thirteenth Five-Year Plan, and projects by the Beijing Municipal Science and Technology Commission. Bell Bio takes human health as its mission, focuses on exploring new testing fields, and has formed a diversified product platform development pattern, capable of providing one-stop and comprehensive testing solutions for clinical laboratories.